abstract |
The present invention relates to a composition for preventing or treating muscle diseases comprising LRRD2 of Slit3 protein to which albumin is bound, and more specifically, to a fusion protein comprising LRRD2 of Slit3 protein to which albumin is bound, encoding the fusion protein. A nucleic acid molecule, a recombinant vector containing the nucleic acid molecule, a transformant containing the recombinant vector, a method for producing a fusion protein using the transformant, a composition for preventing or treating muscle diseases containing the fusion protein, and the It provides a composition for enhancing the half-life in vivo of LRRD2 of Slit3 protein including a fusion protein. |